LCN2 and metabolic disease: This triggers an exaggerated production of lipocalin 2 (Lcn2)—a small iron-transporting protein largely produced by kidney tubular cells, following cellular damage, that is associated with kidney disease progression [44] and other metabolic disorders [45].